(Q46658595)

24 December 2017

title

Total serum cholesterol levels and Alzheimer's dementia in patients with Down syndrome (English)

1 reference

24 December 2017

0 references

V P Prasher

1

1 reference

24 December 2017

E Airuehia

series ordinal

2

1 reference

24 December 2017

A Patel

series ordinal

3

1 reference

24 December 2017

M S Haque

series ordinal

4

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

24 December 2017

International Journal of Geriatric Psychiatry

published in

1 reference

24 December 2017

volume

23

1 reference

24 December 2017

issue

9

1 reference

24 December 2017

page(s)

937-942

1 reference

24 December 2017

Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans

cites work

1 reference

Cholesterol and neuropathologic markers of AD: a population-based autopsy study

21 January 2018

1 reference

The role of cholesterol and statins in Alzheimer's disease

21 January 2018

1 reference

Diagnosis of dementia in individuals with intellectual disability.

21 January 2018

1 reference

7 January 2021

The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipopro

1 reference

7 January 2021

Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study

1 reference

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

7 January 2021

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study

1 reference

7 January 2021

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

7 January 2021

TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E.

1 reference

7 January 2021

Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels

1 reference

7 January 2021

Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

1 reference

7 January 2021

The pathological association between Down syndrome and Alzheimer disease

1 reference

7 January 2021

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

1 reference

7 January 2021

High total cholesterol levels in late life associated with a reduced risk of dementia.

1 reference

7 January 2021

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

1 reference

7 January 2021

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

1 reference

7 January 2021

Statin therapy in Alzheimer's disease

1 reference

7 January 2021

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study

1 reference

7 January 2021

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome

1 reference

7 January 2021

Is hypercholesterolemia a risk factor for Alzheimer's disease?

1 reference

7 January 2021

Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis

1 reference

7 January 2021

Cholesterol level, statin use and Alzheimer's disease in adults with Down syndrome

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.2014

1 reference

24 December 2017

1 reference

24 December 2017